Skip to main content

Cramer: The biotech that doubled in value last year

Jim Cramer has his eye on this amazing biotech that doubled in value last year, and thinks it could have plenty more upside.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.